Enhanced optineurin E50K–TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Glaucoma is the leading cause for blindness affecting 60 million people worldwide. The optineurin (OPTN) E50K mutation was first identified in familial primary open-angle glaucoma (POAG), the onset of which is not associated with intraocular pressure (IOP) elevation, and is classified as normal-tension glaucoma (NTG). Optineurin (OPTN) is a multifunctional protein and its mutations are associated with neurodegenerative diseases such as POAG and amyotrophic lateral sclerosis (ALS). We have previously described an E50K mutation-carrying transgenic (E50K-tg) mouse that exhibited glaucomatous phenotypes of decreased retinal ganglion cells (RGCs) and surrounding cell death at normal IOP. Further phenotypic analysis of these mice revealed persistent reactive gliosis and E50K mutant protein deposits in the outer plexiform layer (OPL). Over-expression of E50K in HEK293 cells indicated accumulation of insoluble OPTN in the endoplasmic reticulum (ER). This phenomenon was consistent with the results seen in neurons derived from induced pluripotent stem cells (iPSCs) from E50K mutation-carrying NTG patients. The E50K mutant strongly interacted with TANK-binding kinase 1 (TBK1), which prohibited the proper oligomerization and solubility of OPTN, both of which are important for OPTN intracellular transition. Treatment with a TBK1 inhibitor, BX795, abrogated the aberrant insolubility of the E50K mutant. Here, we delineated the intracellular dynamics of the endogenous E50K mutant protein for the first time and demonstrated how this mutation causes OPTN insolubility, in association with TBK1, to evoke POAG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“When harboring genetic mutations associated with disease states, the derivation of these cells from patient-specific sources allows for the ability to study mechanisms underlying diseases, such as glaucoma (Inagaki et al., 2018, Minegishi et al., 2013, Ohlemacher et al., 2016, Teotia et al., 2017b).”
From Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids (2020) · cites this paper as Minegishi et al., 2013
In the citing paper
“Transgenic mice overexpressing the OPTNE50K mutation, which instigates the formation of insoluble OPTN aggregates and results in autophagy blockade, display RGC loss and reduced retinal thickness (Chi et al, 2010; Minegishi et al, 2013).”
From Autophagy in major human diseases (2021) · cites this paper as Minegishi et al, 2013
In the citing paper
“suggesting that a loss of OPTN function or a gain of toxic function likely contributes to disease pathogenesis [82, 83].”
In the citing paper
“Enhanced OPTN binding to TBK1 and increased production of insoluble OPTN has been previously observed in E50K mutant cells”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
pEF-BOS, a powerful mammalian expression vector
Mizushima, S., & Nagata, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5322 · Cited by 1,605
STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway
Tanaka, Y., & Chen, Z. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002521 · Cited by 1,317
Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth
Wild, P., Farhan, H., McEwan, D. G., Wagner, S., Rogov, V. V., Brady, N. R., Richter, B., Korac, J., Waidmann, O., Choudhary, C., et al. (2011) · Science · doi:10.1126/science.1205405 · Cited by 1,298
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Quigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin
Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Héon, E., Krupin, T., Ritch, R., Kreutzer, D., et al. (2002) · Science · doi:10.1126/science.1066901 · Cited by 1,105
The prevalence of primary open-angle glaucoma in Japanese
Iwase, A., Suzuki, Y., Araie, M., Yamamoto, T., Abe, H., Shirato, S., Kuwayama, Y., Mishima, H. K., Shimizu, H., Tomita, G., et al. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.03.029 · Cited by 872
Self-citationAtg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response
Saitoh, T., Fujita, N., Hayashi, T., Takahara, K., Satoh, T., Lee, H., Matsunaga, K., Kageyama, S., Omori, H., Noda, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911267106 · Cited by 854
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722
Cited by
Items 101–137 of 137
Sharif, N. A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101218 · Cited by 8
van der Heide, C. J., Miller, M. A., & Fingert, J. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00007-1 · Cited by 4
OPTN protects retinal ganglion cells and ameliorates neuroinflammation in optic neuropathies
Wang, Q., Wang, Y., Jiang, Y., Donahue, R., Cao, G., Yan, W., Guo, H., Li, Z., Liang, J., Hao, J., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08534-6 · Cited by 3
Towards the development of a human glaucoma disease-in-a-dish model using stem cells
Green, D. I., & Ou, Y. (2015) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.1026329 · Cited by 4
Genetics of primary open-angle glaucoma
Youngblood, H. A., & Liu, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00011-3 · Cited by 5
A novel optinEuRin stress connection in glaucoma
Lafont, É., & Avril, T. (2023) · FEBS Journal · doi:10.1111/febs.16774 · Cited by 3
Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma
Shiga, Y., Hashimoto, K., Fujita, K., Maekawa, S., Sato, K., Kubo, S., Kawase, K., Tokumo, K., Kiuchi, Y., Mori, S., et al. (2023) · Genetics in Medicine Open · doi:10.1016/j.gimo.2023.100839 · Cited by 4
Self-citationHuman Pluripotent Stem Cells as In Vitro Models for Retinal Development and Disease
Sridhar, A., Langer, K. B., Fligor, C. M., Steinhart, M. R., Miller, C. A., Ho-A-Lim, K. T., Ohlemacher, S. K., & Meyer, J. S. (2018) · Fundamental biomedical technologies · doi:10.1007/978-3-319-98080-5_2 · Cited by 3
Wiggs, J. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_165 · Cited by 2
Agarwal, R., & Iezhitsa, I. N. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101228 · Cited by 2
C9ORF72 Deficiency Results in Neurodegeneration in the Zebrafish Retina
Jaroszynska, N., Salzinger, A., Tsarouchas, T. M., Becker, C. G., Becker, T., Lyons, D. A., MacDonald, R. B., & Keatinge, M. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.2128-23.2024 · Cited by 3
“Disease in a Dish” Modeling of Retinal Diseases
Nguyen, H. V., & Tsang, S. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-49479-1_9 · Cited by 2
Update on the Japan Eye Genetics Consortium (JEGC)
Iwata, T. (2018) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-13-0884-0_14 · Cited by 1
Self-citationMaurya, N. (2023) · Exploration of Drug Science · doi:10.37349/eds.2023.00018 · Cited by 1
Medchalmi, S., Sayyad, Z., & Swarup, G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120064 · Cited by 1
C9ORF72 deficiency results in degeneration of the zebrafish retina in vivoPreprint
Jaroszynska, N., Salzinger, A., Tsarouchas, T. M., Becker, C. G., Becker, T., Lyons, D. A., MacDonald, R. B., & Keatinge, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563041 · Cited by 1
Advances in Pluripotent and Adult Stem Cells for Eye Research
Peh, G. S. L., & Wong, R. C. B. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-0787-8_5
Gao, J. (2013) · Institutional Repositories DataBase (IRDB)
Cardiac Arrhythmia Modelling Using iPS Cells
Yuasa, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_4
Self-citationIdentification of the Stress Which Causes Optineurin Aggregation
Inagaki, S., Funato, M., Seki, J., Kawase, C., Ohuchi, K., Ando, S., Nakamura, S., Shimazawa, M., Kaneko, H., & Hara, H. (2019) · Neuroscience & Medicine · doi:10.4236/nm.2019.102010
Nanosystems for Repairing Retinal Degeneration
Singh, D., Dromel, P. C., Wang, S.-B., & Tripathi, A. (2020) · Gels horizons: from science to smart materials · doi:10.1007/978-981-15-7998-1_5
Wiggs, J. L. (2020) · Springer eBooks · doi:10.1007/978-3-319-90495-5_165-1
Other Tests in Glaucoma: Genetic Testing
Wiggs, J. L. (2016) · Springer eBooks · doi:10.1007/978-3-662-49042-6_18
Oyston, L. J., Boccanfuso, L. M., Fitzpatrick, L., Zhang, J., Hallupp, M., Kwok, J. B., & Dobson‐Stone, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.02.494603
Surma, M. L., Anbarasu, K., Dutta, S., Perez, L. J. O., Huang, K.-C., Meyer, J. S., & Das, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497702
Gene Therapy for Neurodegeneration in Glaucoma
Karl, J. J., & Tseng, H. C. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_21
Eye Disease Genetics and Therapeutics
Sharif, N. A., Choudry, N. B., Chaudhry, S. D., & Abraham, A. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_15
Protocol for differentiating patient-derived iPSCs into photoreceptor-like cells
Pan, Y., & Iwata, T. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.104283
Self-citationWhen optineurin meets innate immunity
Zhang, L., Han, J., Yang, Z., Xue, M., & Zheng, C. (2026) · Academia Immunity and Disease · doi:10.20935/acadimmunodis8165
Liao, B., Lyu, C., Jiang, Y., Liu, S. H., Wong, W., Zhang, J., Tsang, H., Xie, J., Chen, L., Zhang, Q., et al. (2026) · eLife · doi:10.7554/elife.111251.3 · Cited by 2
Rabesandratana, O. (2019) · theses.fr (ABES) · doi:10.70675/90803044zeb76z4ef0z9d5bz38e212c54762 · Cited by 1
Fonctions mitochondriales de la protéine Optineurine : neurodégénérescence et cancer
D’Urso, B. (2025) · theses.fr (ABES) · doi:10.70675/fe933860ze386z4ca5zaa6fzfcd35c62ce81
Liao, B., Lyu, C., Jiang, Y., Liu, S. H., Wong, W., Zhang, J., Tsang, H., Xie, J., Chen, L. L., Zhang, Q., et al. (2026) · eLife · doi:10.7554/elife.111251
Liao, B., Lyu, C., Jiang, Y., Liu, S. H., Wong, W., Zhang, J., Tsang, H., Xie, J., Chen, L. L., Zhang, Q., et al. (2026) · eLife · doi:10.7554/elife.111251.1
Genetics, types, and risk factors associated with glaucoma
Badar, M. S., Veqar, A., Tasneem, Z., Jilani, N., Badar, S. S., Ahmad, S., Badar, L. R., Mathur, S. H., Azad, A., Alam, S., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44911-6.00016-4
Minding the gates: dual cell-autonomous and non-cell-autonomous mechanisms of TBK1 in ALS/FTD
Smeyers, J., & Mordes, D. A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1941293
Metadata
- Authors
- Minegishi, Y., Iejima, D., Kobayashi, H., Chi, Z.-L., Kawase, K., Yamamoto, T., Seki, T., Yuasa, S., Fukuda, K., & Iwata, T.
- Affiliations
- Tokyo Medical Center (JP)
- Gifu University (JP)
- Keio University (JP)
- Corresponding author
- Iwata, Takeshi
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-12
- Volume
- 22
- Issue
- 17
- Pages
- 3559-3567
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2138674139
- Cited by
- 138
- References
- 47
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 10 · 2016: 20 · 2015: 19 · 2014: 8 · 2013: 3
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24791885)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- optineurin, normal-tension glaucoma, TBK1, protein insolubility, protein aggregation, retinal ganglion cells, reactive gliosis, outer plexiform layer, endoplasmic reticulum, protein oligomerization, BX795, TBK1 inhibitors, iPSC-derived neurons, transgenic mouse model
- MeSH terms
- Animals, Disease Models, Animal, Endoplasmic Reticulum, Glaucoma, Open-Angle, Gliosis, Humans, Mice, Transgenic, Pyrimidines, Retina, Thiophenes, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Membrane Transport Proteins, Transcription Factor TFIIIA, Mice, Induced Pluripotent Stem Cells, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.